Mark Aagren
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Family Practice top 5%
Papers in
-
- Diabetes Management and Research 14
- Growth Hormone and Insulin-like Growth Factors 2
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 1
-
- Allergic Rhinitis and Sensitization 5
- Co-authors
- Jonathan Bouchard (13 shared papers)Stephen S. Johnston (2 shared papers)Kimberly Ruiz (1 shared paper)Christopher S. Conner (2 shared papers)Won Chan Lee (3 shared papers)Wei Luo (4 shared papers)Jason Brett (1 shared paper)David M. Smith (1 shared paper)
- Journals
- Current Medical Research and Opinion (11 papers)Journal of Medical Economics (5 papers)Value in Health (5 papers)Clinical Therapeutics (3 papers)Diabetes Obesity and Metabolism (2 papers)
- Partner nations
- United StatesDenmarkUnited Kingdom
In The Last Decade
Mark Aagren
39 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 91
- Endocrinology, Diabetes and Metabolism 526
- Family Practice 44
- Ophthalmology 93
- Orthopedics and Sports Medicine 57
- Geriatrics and Gerontology 18
Countries citing papers authored by Mark Aagren
This map shows the geographic impact of Mark Aagren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Aagren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Aagren more than expected).
Fields of papers citing papers by Mark Aagren
This network shows the impact of papers produced by Mark Aagren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Aagren. The network helps show where Mark Aagren may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Aagren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 185 | |
| 2 | 2011 | 147 | |
| 3 | 2012 | 81 | |
| 4 | 2005 | 60 | |
| 5 | 2010 | 51 | |
| 6 | 2008 | 48 | |
| 7 | 2011 | 43 | |
| 8 | 2012 | 40 | |
| 9 | 2009 | 34 | |
| 10 | 2008 | 33 | |
| 11 | 2010 | 32 | |
| 12 | 2010 | 31 | |
| 13 | 2011 | 30 | |
| 14 | 2012 | 28 | |
| 15 | 2009 | 23 | |
| 16 | 2008 | 22 | |
| 17 | 2013 | 17 | |
| 18 | 2006 | 15 | |
| 19 | 2009 | 14 | |
| 20 | 2009 | 14 |
About Mark Aagren
Mark Aagren is a scholar working on Endocrinology, Diabetes and Metabolism, Immunology and Allergy, Economics and Econometrics, Ophthalmology and Physiology, having authored 42 papers that have together received 1.1k indexed citations. Recurring topics across this work include Diabetes Management and Research (14 papers), Allergic Rhinitis and Sensitization (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Growth Hormone and Insulin-like Growth Factors (2 papers), Glaucoma and retinal disorders (2 papers), Ophthalmology and Visual Impairment Studies (1 paper), Hyperglycemia and glycemic control in critically ill and hospitalized patients (1 paper) and Pharmaceutical industry and healthcare (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (526 citations), Family Practice (44 citations), Ophthalmology (93 citations), Orthopedics and Sports Medicine (57 citations) and Geriatrics and Gerontology (18 citations). Mark Aagren has collaborated with scholars based in United States, Denmark and United Kingdom. Frequent co-authors include Jonathan Bouchard, Stephen S. Johnston, Kimberly Ruiz, Christopher S. Conner, Won Chan Lee, Wei Luo, Jason Brett, David M. Smith, Torsten Christensen and P. Buchholz. Their work appears in journals such as Current Medical Research and Opinion, Journal of Medical Economics, Value in Health, Clinical Therapeutics and Diabetes Obesity and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.